This is an observational, controlled, single-centre study to validate the Thora3Di™ against standard practice in patients who are undergoing investigation for disproportionate breathlessness. The core methodology involves capturing of data during a short period of measurement of breathing using SLP.
Cohort A: This study is a pilot study with four study visits (Screening, Baseline, week 13 and week 26) to generate data to characterise the tidal breathing patterns and parameters with Thora3Di™. Subjects will have a screening visit within 0 to 14 days prior to the first study visit. For each study visit, subjects will be seen in the clinical research facility and have two 5-minute SLP measurements (at rest and on exertion). The SLP measurement should be performed prior to standard lung function tests with minimal impact on clinical time and not change to hospital attendance. Also, each visit subjects will be asked to report concomitant medications and adverse events, and fill several questionnaires forms as outlined in the SOAs. Cohort B: Healthy subjects will have only one visit for this study. After signing the informed consent form, subjects will undergo two 5-minutes SLP measurements (at rest and on exertion).
Study Type
OBSERVATIONAL
Enrollment
60
Not international
Pneuma Care Ltd
Ely, Cambridgeshire, United Kingdom
Estabilsih expected value and dispersion of Structured Light Phlethysmography in Dysfunctional breathing patients
Measure SLP parameters during the course of the treatment : Baseline, Week 13 and Week 26 at rest and at exertion
Time frame: 26 weeks
Establish a relationship between Structured Light Phlethysmography parameters and patient report outcomes addressed.
Compare SLP parameters with patient outcome reports (Nijmegen and St George Respiratory Questionnaires and BPAT and BORG scores during the course of the treatment
Time frame: 26 weeks
Establish different SLP parameters between patients with dysfunctional breathing and healthy subjects.
Compare the differences in SLP parameters between patients with dysfunctional breathing and healthy subjects
Time frame: 26 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.